Finance

Lists
Why is T14 up 4,67%?
Dive Deeper
T14:SGX
Tianjin Pharmcetl Da Ren Tang Grp Cp Ltd
2,69 US$
+4,67%
(+0,12) 1D
19 ოქტ, 13:25:28 GMT+8  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for T14...
Open
2,57 US$
High
2,70 US$
Low
2,57 US$
Mkt. cap
3,68 მლრდ.
Avg. vol.
126,65 ათ.
Volume
185,40 ათ.
52-wk high
3,75 US$
52-wk low
2,45 US$
Shares outstanding
200,00 მლნ.
No. of employees
4 ათ.
Open
2,57 US$
High
2,70 US$
Low
2,57 US$
Mkt. cap
3,68 მლრდ.
Avg. vol.
126,65 ათ.
Volume
185,40 ათ.
52-wk high
3,75 US$
52-wk low
2,45 US$
Shares outstanding
200,00 მლნ.
No. of employees
4 ათ.
News stories
From web sources and news partners
About Tianjin Pharmcetl Da Ren Tang Grp Cp Ltd
CEO-
Employees3,89 ათ.
Founded1915
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,02 მლრდ.
1,25 მლრდ.
1,52 მლრდ.
939,39 მლნ.
Cost of goods sold
238,27 მლნ.
394,31 მლნ.
337,79 მლნ.
292,96 მლნ.
Cost of revenue
238,27 მლნ.
394,31 მლნ.
337,79 მლნ.
292,96 მლნ.
Research and development expenses
43,07 მლნ.
85,19 მლნ.
29,81 მლნ.
50,15 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
514,66 მლნ.
696,15 მლნ.
625,03 მლნ.
371,90 მლნ.
Operating expense
563,62 მლნ.
807,49 მლნ.
677,84 მლნ.
441,00 მლნ.
Total operating expenses
801,90 მლნ.
1,20 მლრდ.
1,02 მლრდ.
733,96 მლნ.
Operating income
217,44 მლნ.
45,67 მლნ.
499,57 მლნ.
205,42 მლნ.
Other non operating income
-2,64 მლნ.
1,48 მლნ.
-450,84 ათ.
-152,55 ათ.
EBT including unusual items
253,19 მლნ.
-32,76 მლნ.
494,29 მლნ.
258,05 მლნ.
EBT excluding unusual items
265,54 მლნ.
66,32 მლნ.
529,85 მლნ.
223,56 მლნ.
Income tax expense
30,06 მლნ.
2,71 მლნ.
71,23 მლნ.
37,55 მლნ.
Effective tax rate
11,87%
-8,27%
14,41%
14,55%
Other operating expenses
5,74 მლნ.
28,38 მლნ.
20,68 მლნ.
14,35 მლნ.
Net income
224,56 მლნ.
-21,16 მლნ.
423,80 მლნ.
220,94 მლნ.
Net profit margin
22,03%
-1,70%
27,97%
23,52%
Earnings per share
-
-
-
-
Interest and investment income
52,79 მლნ.
22,29 მლნ.
33,73 მლნ.
20,96 მლნ.
Interest expense
-2,01 მლნ.
-2,32 მლნ.
-3,00 მლნ.
-2,18 მლნ.
Net interest expenses
50,78 მლნ.
19,97 მლნ.
30,73 მლნ.
18,79 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
247,23 მლნ.
72,82 მლნ.
526,71 მლნ.
230,47 მლნ.
Gain or loss from assets sale
74,81 ათ.
-2,83 მლნ.
-
181,42 ათ.
AI content may include mistakes. Learn more
Google აპები